Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JD.Com Inc (JD) vs Viatris Inc (VTRS) Price & Performance

JD.Com IncTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

JD.Com Inc vs Viatris Inc — how do they compare? JD.Com Inc trades at $31.45 (market cap $45.40B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: JD.Com Inc is far larger — about 2.4× Viatris Inc's market cap, and JD.Com Inc pays the higher dividend (2.99%). Which is the better fit depends on your goals.

JDVTRS
Market Cap
$45.40B$18.69B
Sector
Consumer CyclicalHealth
52-Week High
$36.17$17.86
52-Week Low
$25.19$9.49
Enterprise Value
$31.45B$30.81B
Dividend Yield
2.99%2.95%

Returns comparison

Trailing returns across standard periods

About JD.Com Inc

JD.com is China's second-largest e-commerce company after Alibaba in terms of gross merchandise volume, offering a wide selection of authentic products at competitive prices, with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.

Read more on JD

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS